![](/img/cover-not-exists.png)
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Raizer, J. J., Abrey, L. E., Lassman, A. B., Chang, S. M., Lamborn, K. R., Kuhn, J. G., Yung, W.K. A., Gilbert, M. R., Aldape, K. A., Wen, P. Y., Fine, H. A., Mehta, M., DeAngelis, L. M., Lieberman, FVolume:
12
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nop015
Date:
January, 2010
File:
PDF, 155 KB
english, 2010